Frontiers in Neuroscience · 2017 · 80 citations · 38 references
Life SciencesNeurobiologyNeuroscienceDementiaMitochondrial BiologyNeurodegenerationAlzheimer DiseaseDementia BiomarkersMitochondrial BioenergeticsMitochondrial DysfunctionMitochondrial FunctionMitochondrial FusionBiomarker-based Early DetectionMitochondrial Dysfunction BiomarkersMitochondrial Dysfunction In AgingMitochondrial Fusion MachineryMitochondrial NeuropathologyNeurodegenerative Mitochondrial DysfunctionNeuropathological BiomarkersProteolytic Processing Analysis
The identification of an early biomarker to diagnose Alzheimer's disease (AD) remains a challenge. Neuropathological studies in animal and AD patients have shown that mitochondrial dysfunction is a hallmark of the development of the disease. Current studies suggest the use of peripheral tissues, like skin fibroblasts as a possibility to detect the early pathological alterations present in the AD brain. In this context, we studied mitochondrial function properties (bioenergetics and morphology) in cultured fibroblasts obtained from AD, aged-match and young healthy patients. We observed that AD fibroblasts presented a significant reduction in mitochondrial length with important changes in the expression of proteins that control mitochondrial fusion. Moreover, AD fibroblasts showed a distinct alteration in proteolytic processing of OPA1, a master regulator of mitochondrial fusion, compared to control fibroblasts. Complementary to these changes AD fibroblasts showed a dysfunctional mitochondrial bioenergetics profile that differentiates these cells from aged-matched and young patient fibroblasts. Our findings suggest that the human skin fibroblasts obtained from AD patients could replicate mitochondrial impairment observed in the AD brain. These promising observations suggest that the analysis of mitochondrial bioenergetics could represent a promising strategy to develop new diagnostic methods in peripheral tissues of AD patients.
38
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
The Clinical Dementia Rating (CDR)
John C. Morris · Neurology · 1993 · 10K citations
Medicine, Neurology, Psychiatry +12
ER Tubules Mark Sites of Mitochondrial Division
Jonathan R. Friedman, Laura L. Lackner, Matthew West et al. · Science · 2011 · 2.1K citations
How common are the “common” neurologic disorders?
Deborah Hirtz, David J. Thurman, Katrina Gwinn et al. · Neurology · 2007 · 1.4K citations
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Xinglong Wang, Bo Su, Hyoung‐gon Lee et al. · Journal of Neuroscience · 2009 · 1.2K citations · Full text